(ZM) Zoom Video Communications - Ratings and Ratios
Video, Phone, Chat, Contact, Center, Webinar
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 31.1% |
| Value at Risk 5%th | 48.8% |
| Relative Tail Risk | -4.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.14 |
| Alpha | -12.54 |
| CAGR/Max DD | 0.19 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.483 |
| Beta | 0.867 |
| Beta Downside | 0.863 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.66% |
| Mean DD | 16.43% |
| Median DD | 17.37% |
Description: ZM Zoom Video Communications December 17, 2025
Zoom Communications, Inc. (NASDAQ: ZM) markets an AI-first work platform that bundles video-conferencing, cloud-phone, messaging, calendar, workflow automation, document collaboration, whiteboarding, and contact-center solutions under a single subscription umbrella. The suite spans Zoom Meetings, Zoom Phone, Zoom Team Chat, Zoom Docs, Zoom Whiteboard, Zoom Clips, Zoom Events, Zoom Webinars, Zoom Rooms, and a developer ecosystem that includes an app marketplace and no-code workflow builder, serving a broad range of verticals from enterprise infrastructure to education and healthcare.
Key recent metrics: FY 2023 revenue reached $4.1 billion, up ~12 % YoY, driven by a 19 % increase in annual recurring revenue (ARR) to roughly $2.5 billion and a modest net-revenue retention rate of 106 %, indicating effective upsell of AI-enhanced features such as Zoom IQ. The primary macro drivers remain sustained hybrid-work adoption, enterprise budgets for digital collaboration, and the acceleration of AI-powered productivity tools, while competitive pressure from Microsoft Teams and Google Meet continues to compress pricing in the application-software sub-industry.
For a deeper, data-driven assessment of Zoom’s valuation and risk profile, you may find the analytical dashboards on ValueRay worth a look.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.59b TTM) > 0 and > 6% of Revenue (6% = 288.4m TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 1.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 136.9% (prev 144.3%; Δ -7.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 2.06b > Net Income 1.59b (YES >=105%, WARN >=100%) |
| Net Debt (-1.18b) to EBITDA (1.23b) ratio: -0.96 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.36 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (308.7m) change vs 12m ago -1.75% (target <= -2.0% for YES) |
| Gross Margin 76.89% (prev 75.83%; Δ 1.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 43.55% (prev 43.33%; Δ 0.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.21 (EBITDA TTM 1.23b / Interest Expense TTM -910.2m) >= 6 (WARN >= 3) |
Altman Z'' 8.41
| (A) 0.58 = (Total Current Assets 8.54b - Total Current Liabilities 1.96b) / Total Assets 11.39b |
| (B) 0.44 = Retained Earnings (Balance) 5.03b / Total Assets 11.39b |
| (C) 0.10 = EBIT TTM 1.10b / Avg Total Assets 11.04b |
| (D) 2.39 = Book Value of Equity 5.04b / Total Liabilities 2.10b |
| Total Rating: 8.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.99
| 1. Piotroski 6.50pt |
| 2. FCF Yield 8.12% |
| 3. FCF Margin 41.64% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda -0.96 |
| 6. ROIC - WACC (= 0.20)% |
| 7. RoE 17.67% |
| 8. Rev. Trend 97.74% |
| 9. EPS Trend 17.51% |
What is the price of ZM shares?
Over the past week, the price has changed by -0.63%, over one month by -3.74%, over three months by +5.84% and over the past year by +4.15%.
Is ZM a buy, sell or hold?
- Strong Buy: 12
- Buy: 1
- Hold: 19
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the ZM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95 | 10.7% |
| Analysts Target Price | 95 | 10.7% |
| ValueRay Target Price | 87.8 | 2.4% |
ZM Fundamental Data Overview January 03, 2026
P/E Trailing = 16.7879
P/E Forward = 14.245
P/S = 5.3737
P/B = 2.7513
P/EG = 4.7464
Beta = 0.808
Revenue TTM = 4.81b USD
EBIT TTM = 1.10b USD
EBITDA TTM = 1.23b USD
Long Term Debt = 48.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 20.4m USD (from shortTermDebt, last quarter)
Debt = 48.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.18b USD (from netDebt column, last quarter)
Enterprise Value = 24.66b USD (25.83b + Debt 48.5m - CCE 1.22b)
Interest Coverage Ratio = -1.21 (Ebit TTM 1.10b / Interest Expense TTM -910.2m)
FCF Yield = 8.12% (FCF TTM 2.00b / Enterprise Value 24.66b)
FCF Margin = 41.64% (FCF TTM 2.00b / Revenue TTM 4.81b)
Net Margin = 33.17% (Net Income TTM 1.59b / Revenue TTM 4.81b)
Gross Margin = 76.89% ((Revenue TTM 4.81b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 77.90% (prev 77.56%)
Tobins Q-Ratio = 2.16 (Enterprise Value 24.66b / Total Assets 11.39b)
Interest Expense / Debt = 69.10% (Interest Expense 33.5m / Debt 48.5m)
Taxrate = 22.88% (181.8m / 794.7m)
NOPAT = 847.4m (EBIT 1.10b * (1 - 22.88%))
Current Ratio = 4.36 (Total Current Assets 8.54b / Total Current Liabilities 1.96b)
Debt / Equity = 0.01 (Debt 48.5m / totalStockholderEquity, last quarter 9.29b)
Debt / EBITDA = -0.96 (Net Debt -1.18b / EBITDA 1.23b)
Debt / FCF = -0.59 (Net Debt -1.18b / FCF TTM 2.00b)
Total Stockholder Equity = 9.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.99% (Net Income 1.59b / Total Assets 11.39b)
RoE = 17.67% (Net Income TTM 1.59b / Total Stockholder Equity 9.02b)
RoCE = 12.12% (EBIT 1.10b / Capital Employed (Equity 9.02b + L.T.Debt 48.5m))
RoIC = 9.40% (NOPAT 847.4m / Invested Capital 9.02b)
WACC = 9.19% (E(25.83b)/V(25.87b) * Re(9.21%) + (debt cost/tax rate unavailable))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.27%
[DCF Debug] Terminal Value 75.95% ; FCFE base≈1.89b ; Y1≈2.12b ; Y5≈2.83b
Fair Price DCF = 149.9 (DCF Value 39.82b / Shares Outstanding 265.6m; 5y FCF grow 14.12% → 3.0% )
EPS Correlation: 17.51 | EPS CAGR: 12.55% | SUE: 4.0 | # QB: 13
Revenue Correlation: 97.74 | Revenue CAGR: 3.75% | SUE: 2.10 | # QB: 3
EPS next Quarter (2026-04-30): EPS=0.82 | Chg30d=+0.012 | Revisions Net=-1 | Analysts=7
EPS next Year (2027-01-31): EPS=3.55 | Chg30d=+0.099 | Revisions Net=+5 | Growth EPS=-26.6% | Growth Revenue=+3.5%
Additional Sources for ZM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle